Anastrozole Market 2028 by Route of Administration, Distribution Channel and Geography | The Insight Partners

report image

Anastrozole Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Route of Administration (Oral, Intravenous and Intramuscular); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography

Report Code: TIPRE00008223 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Anastrozole is an aromatase inhibitor, which helps to decrease the overall levels of estrogen in a woman's body. The compound is prescribed for women who have had menopause. Anastrozole is preferred as a treatment for breast cancer among women. By the administration of this drug, estrogen is blocked, due to which the cancer cells feeding off estrogen may be unable able to survive.


The anastrozole market is anticipated to grow in the forecast, owing to the rising number of breast cancer cases. Also, the supportive government policies for cancer treatment are likely to offer significant growth opportunities in the market during the forecast period.


The "Anastrozole Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of anastrozole market with detailed market segmentation by route of administration, distribution channel and geography. The anastrozole market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anastrozole market players and offers key trends and opportunities in the market.


The anastrozole market is segmented on the basis of route of administration and distribution channel. Based on mode of administration the market is segmented as, oral, intravenous and intramuscular. On the basis of distribution channel the market is categorized as, hospital pharmacies and retail pharmacies.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anastrozole market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anastrozole market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anastrozole market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anastrozole market in these regions.

Get more information on this report :


The report covers key developments in the anastrozole market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anastrozole market are anticipated to have lucrative growth opportunities in the future with the rising demand for anastrozole market in the global market. Below mentioned is the list of few companies engaged in the anastrozole market.

The report also includes the profiles of key anastrozole market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Accord Healthcare Ireland Ltd
  •  Apotex Inc.
  •  Cipla Limited
  •  Hisun Pharmaceuticals USA Inc.
  •  Mylan N.V.
  •  Natco Pharma (Canada) Inc.
  •  Synthon
  •  Teva Pharmaceuticals USA, Inc.
  •  Zydus Pharmaceuticals, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Accord Healthcare Ireland Ltd
2. Apotex Inc.
3. Cipla Limited
4. Hisun Pharmaceuticals USA Inc.
6. Mylan N.V.
7. Natco Pharma (Canada) Inc.
8. Synthon
9. Teva Pharmaceuticals USA, Inc.
10. Zydus Pharmaceuticals, Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount